Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-071985

Chief Financial Officer sold 398 shares at $8.22 ($3,272)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2023-12-18 Sale −398 $8.22 $3,272 85,839 D
Open-market sales · 398 sh · avg $8.22 · $3,272
Loading xslF345X05/ownership.xml…